Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells

doi:10.3748/wjg.15.310

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4303)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-4) series.

Item

Count

PDF

285

HTML

3630

Figures (1-7)

237

Tables (1-4)

151

Sum=4303

Jan 21, 2009 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Jan 21, 2009; 15(3): 310-320
Published online Jan 21, 2009. doi: 10.3748/wjg.15.310

Full Size Figure Download Figure

Figure 7 Effect of GW9662 on the inhibition of cell proliferation. GW9662, a selective PPAR-γ suppressor, had no effect on ciglitazone- or troglitazone-induced inhibition of cell proliferation. ^aP < 0.05 vs control group.

Citation: Cheon CW, Kim DH, Kim DH, Cho YH, Kim JH. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol 2009; 15(3): 310-320
URL: https://www.wjgnet.com/1007-9327/full/v15/i3/310.htm
DOI: https://dx.doi.org/10.3748/wjg.15.310